Sarcosine, a key oncometabolite in prostate cancer (PCa), has emerged as a promising biomarker for disease diagnosis and progression monitoring. However, conventional detection methods often rely on urine samples and are susceptible to interference from indivi... ...

请注册登录后继续浏览